• Profile
Close

The influence of a breast cancer diagnosis on serum 25-hydroxyvitamin D

American Journal of Epidemiology Jan 09, 2019

O'Brien KM, et al. - Researchers determined the impact of a breast cancer diagnosis on serum 25-hydroxyvitamin D (25[OH]D) concentrations in Sister Study participants: 827 women with an intervening breast cancer and 771 without. The investigators measured participant total serum 25(OH)D levels at baseline (2003-2009) and 4-10 years later (2013-2015). In both groups, increased 25(OH)D concentrations were detected, although modestly correlated over time; however, they observed larger increases among women with breast cancer vs those without. Consequently, whether baseline or second blood draw measures were used was found to be a decisive factor for the estimated link between 25(OH)D and breast cancer. Findings revealed association of concentrations with regular (> 4 times/week) vitamin D supplement use, which became more common over time. In patients with breast cancer (56% to 84%) vs in control participants (56% to 77%), greater increases were observed. Overall, previously observed differences between retrospective and prospective studies were not explained by the findings but do show how reverse causation and temporal trends in exposure can distort inference.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay